Unity Biotechnology Inc (NASDAQ:UBX) price closed higher on current market day and jumping 16.00% above its previous close.
A look at the daily price movement shows that the last close reads $0.70. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.10 and 52-week low of $0.66. The stock subtracted -11.39% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 3 analysts have assigned UBX a recommendation rating as follows: 0 rate it as a Hold; 3 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Unity Biotechnology Inc (UBX) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that UBX’s price is at present 9.20% off the SMA20 and -8.34% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 50.75, with weekly volatility standing at 8.54%. The indicator jumps to 5.92% when calculated based on the past 30 days. Unity Biotechnology Inc (NASDAQ:UBX)’s beta value is holding at 1.06, while the average true range (ATR) indicator is currently reading 0.09. Considering analysts have assigned the stock a price target range of $1-$4 as the low and high respectively, we find the trailing 12-month average consensus price target to be $2.5. Based on this estimate, we see that current price is roughly -23.46% off the estimated low and -393.83% off the forecast high. Investors will no doubt be excited to see the share price fall to $2.5, which is the median consensus price, and at that level UBX would be -208.64% from current price.
Current records show that the company has 17.21M in outstanding shares. The insiders’ percentage holdings are 8.92% of outstanding shares while the percentage share held by institutions stands at 11.46%. But the -17.04% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
